$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000114519715000066 Filed on November 06, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$83.80M	$71.39M	$60.03M
YoY Change	43.58%	18.93%	-1.76%
Cost Of Revenue	$41.80M	$39.82M	$36.94M
YoY Change	-888.68%	7.8%	9.6%
Gross Profit	$41.99M	$31.57M	$33.74M
YoY Change	26.8%	-6.44%	23.17%
Gross Profit Margin	50.11%	44.22%	56.21%
Selling, General & Admin	$41.70M	$36.33M	$33.76M
YoY Change	244.63%	7.61%	-13.3%
% of Gross Profit	99.3%	115.08%	100.05%
Research & Development	$12.90M	$10.04M	$7.158M
YoY Change	76.71%	40.19%	24.03%
% of Gross Profit	30.72%	31.79%	21.21%
Depreciation & Amortization	$4.430M	$4.300M	$3.070M
YoY Change	45.25%	40.07%	-0.97%
% of Gross Profit	10.55%	13.62%	9.1%
Operating Expenses	$54.60M	$46.37M	$40.92M
YoY Change	182.9%	13.31%	-8.48%
Operating Profit	-$12.62M	-$14.79M	-$2.876M
YoY Change	-191.31%	414.39%	-83.39%
Interest Expense	-$3.200M	-$3.100M	-$3.700M
YoY Change	6.67%	-16.22%	-3800.0%
% of Operating Profit
Other Income/Expense, Net		-$3.146M	-$7.948M
YoY Change		-60.42%	100.1%
Pretax Income	-$15.80M	-$17.94M	-$10.82M
YoY Change	731.58%	65.75%	-49.15%
Income Tax	$100.0K	$44.00K	$21.00K
% Of Pretax Income
Net Earnings	-$27.33M	-$18.93M	-$10.85M
YoY Change	406.06%	74.52%	-49.06%
Net Earnings / Revenue	-32.61%	-26.51%	-18.07%
Basic Earnings Per Share
Diluted Earnings Per Share	-$479.8K	-$332.2K	-$193.5K
COMMON SHARES
Basic Shares Outstanding	56.93M shares	56.90M shares	55.88M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$122.7M	$145.5M	$146.4M
YoY Change	-18.85%	-0.61%	-4.87%
Cash & Equivalents	$122.7M	$145.5M	$146.4M
Short-Term Investments	$0.00
Other Short-Term Assets	$13.60M	$4.000M	$3.400M
YoY Change	240.0%	17.65%	-42.37%
Inventory	$12.02M	$13.02M	$9.662M
Prepaid Expenses
Receivables	$42.53M	$31.80M	$47.15M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$190.8M	$194.3M	$206.6M
YoY Change	-8.37%	-5.94%	3.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.79M	$41.54M	$36.58M
YoY Change	13.13%	13.54%	16.51%
Goodwill	$39.61M	$2.403M	$37.54M
YoY Change	5.91%	-93.6%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$76.00K	$4.384M	$5.493M
YoY Change	-74.15%	-20.19%	219.17%
Total Long-Term Assets	$84.37M	$98.78M	$94.58M
YoY Change	-5.19%	4.44%	5.32%
TOTAL ASSETS
Total Short-Term Assets	$190.8M	$194.3M	$206.6M
Total Long-Term Assets	$84.37M	$98.78M	$94.58M
Total Assets	$275.1M	$293.1M	$301.2M
YoY Change	-7.42%	-2.68%	4.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.21M	$15.61M	$17.73M
YoY Change	20.93%	-11.91%	17.26%
Accrued Expenses	$36.74M	$35.55M	$25.21M
YoY Change	94.93%	40.98%	-16.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.500M	$6.000M	$4.000M
YoY Change	61.76%	50.0%
Total Short-Term Liabilities	$65.16M	$59.44M	$47.76M
YoY Change	47.09%	24.44%	-1.1%
LONG-TERM LIABILITIES
Long-Term Debt	$171.7M	$173.9M	$167.4M
YoY Change	4.68%	3.85%	50.67%
Other Long-Term Liabilities	$3.952M	$3.619M	$2.580M
YoY Change	42.47%	40.27%	0.51%
Total Long-Term Liabilities	$175.7M	$177.5M	$170.0M
YoY Change	5.31%	4.41%	49.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.16M	$59.44M	$47.76M
Total Long-Term Liabilities	$175.7M	$177.5M	$170.0M
Total Liabilities	$241.1M	$238.0M	$220.9M
YoY Change	12.99%	7.76%	31.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$651.5M	-$624.2M	-$572.6M
YoY Change	12.72%	9.01%	9.27%
Common Stock	$57.00K	$57.00K	$56.00K
YoY Change	1.79%	1.79%	1.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.05M	$55.13M	$80.34M
YoY Change
Total Liabilities & Shareholders Equity	$275.1M	$293.1M	$301.2M
YoY Change	-7.42%	-2.68%	4.04%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$27.33M	-$18.93M	-$10.85M
YoY Change	406.06%	74.52%	-49.06%
Depreciation, Depletion And Amortization	$4.430M	$4.300M	$3.070M
YoY Change	45.25%	40.07%	-0.97%
Cash From Operating Activities	-$18.59M	$8.740M	$4.820M
YoY Change	-503.25%	81.33%	30.27%
INVESTING ACTIVITIES
Capital Expenditures	-$3.480M	-$2.530M	-$3.100M
YoY Change	31.82%	-18.39%	70.33%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$4.720M
YoY Change
Cash From Investing Activities	-$3.480M	-$7.240M	-$3.100M
YoY Change	31.82%	133.55%	70.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-660.0K	-960.0K	-30.88M
YoY Change	-123.24%	-96.89%	-2933.03%
NET CHANGE
Cash From Operating Activities	-18.59M	8.740M	4.820M
Cash From Investing Activities	-3.480M	-7.240M	-3.100M
Cash From Financing Activities	-660.0K	-960.0K	-30.88M
Net Change In Cash	-22.73M	540.0K	-29.16M
YoY Change	-572.56%	-101.85%	-1081.82%
FREE CASH FLOW
Cash From Operating Activities	-$18.59M	$8.740M	$4.820M
Capital Expenditures	-$3.480M	-$2.530M	-$3.100M
Free Cash Flow	-$15.11M	$11.27M	$7.920M
YoY Change	-308.41%	42.3%	43.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	podd	Return Period ReturnPeriod	P45D
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56928573	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	INSULET CORP
	dei	Trading Symbol TradingSymbol	PODD
	podd	Allocationtoequityforconversionforthe2 Notes Allocationtoequityforconversionforthe2Notes	35638000	USD
	podd	Allocationtoequityforconversionforthe2 Notes Allocationtoequityforconversionforthe2Notes	0	USD
CY2015Q3	podd	Business Combination Preacquisition Obligation BusinessCombinationPreacquisitionObligation	500000	USD
CY2014Q3	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	962000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	3583000	USD
CY2015Q3	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	1007000	USD
	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	3019000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	3861000	USD
	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	11782000	USD
CY2014Q3	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	7047000	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	33832000	USD
CY2015Q3	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	2938000	USD
	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	8739000	USD
CY2014Q4	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	2	customer
CY2015Q3	podd	Number Of Customers With Greater Than Ten Percent Accounts Receivable Balance NumberOfCustomersWithGreaterThanTenPercentAccountsReceivableBalance	1	customer
CY2015Q3	podd	Number Of Financial Institution NumberOfFinancialInstitution	2	location
CY2015Q3	podd	Number Of Inches Of Tubing In Conventional Insulin Pump NumberOfInchesOfTubingInConventionalInsulinPump	42	in
CY2014Q4	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	customer
CY2015Q1	podd	Number Of Single Source Suppliers NumberOfSingleSourceSuppliers	1	customer
CY2014	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.24
	podd	Percentage Of Accounts Payable Accrued Expensesand Other Current Liabilities PercentageOfAccountsPayableAccruedExpensesandOtherCurrentLiabilities	0.26
	podd	Percentof Revenue PercentofRevenue	0.11
	podd	Product Warranty Term ProductWarrantyTerm	P4Y
	podd	Productlosscontingency Productlosscontingency	100000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	59000	USD
	podd	Return Period Canada ReturnPeriodCanada	P90D
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14659000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15614000	USD
CY2014Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	45719000	USD
CY2015Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37709000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39882000	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31803000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	24703000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35547000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-13000	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-467000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P6Y4M2D
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	661811000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	679761000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9600000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18200000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4200000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13800000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5837000	USD
CY2015Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5906000	USD
CY2014Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1548000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6431000	USD
CY2015Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1650000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4876000	USD
CY2014Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	277000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	615000	USD
CY2015Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	281000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	844000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8397000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	5721000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3100000	USD
CY2015Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	USD
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6663318	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6663318	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8148621	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8148621	shares
CY2014Q4	us-gaap	Assets Assets	302156000	USD
CY2015Q3	us-gaap	Assets Assets	293120000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	208196000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	194338000	USD
CY2015Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	100000	USD
CY2015Q3	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	4715000	USD
CY2015Q3	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	-285000	USD
CY2015Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	2100000	USD
CY2015Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	230000	USD
CY2015Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	18000	USD
CY2015Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	4715000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3380000	USD
CY2015Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	6020000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1474000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	5721000	USD
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	2263000	USD
CY2015Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	1061000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	7670000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5639000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	269000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	589000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	7081000	USD
CY2015Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1762000	USD
CY2014Q3	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	400000	USD
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	1000000	USD
CY2015Q3	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	300000	USD
	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	1000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	149727000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	146372000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	151193000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145467000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	123141000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	108196000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3355000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-5726000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56299022	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56914557	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56299022	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56914557	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	56000	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	57000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10844000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-46100000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19384000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-46647000	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	36943000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	109544000	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51652000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	121273000	USD
CY2014Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11406000	USD
CY2015Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	44000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	84000	USD
CY2014Q3	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	348535	shares
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	32256000	USD
CY2015Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	27380000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4974000	USD
CY2015Q3	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4130000	USD
CY2014Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	79000	USD
CY2015Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	67000	USD
CY2014Q4	us-gaap	Deferred Revenue DeferredRevenue	1600000	USD
CY2015Q3	us-gaap	Deferred Revenue DeferredRevenue	2400000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1554000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2256000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9168000	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.83
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.33
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.81
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-220000	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	41700000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18836000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21860000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2720000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	3101000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1261000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1625000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1961000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2371000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32900000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34899000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14064000	USD
CY2015Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13039000	USD
CY2011	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	32900000	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4260000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23203000	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-23200000	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18890000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	52661000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17156000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45841000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	37536000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	39823000	USD
CY2015Q3	us-gaap	Goodwill Goodwill	2403000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	38042000	USD
	us-gaap	Gross Profit GrossProfit	106615000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	35651000	USD
	us-gaap	Gross Profit GrossProfit	102833000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10824000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-45962000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18865000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-46042000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	138000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	62000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	151000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16747000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5286000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-66000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	703000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	198000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-312000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	637000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	370000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1242000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-42000	USD
CY2014Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3043000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	11507000	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3167000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	9435000	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11992000	USD
CY2015Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11852000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	13099000	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	13019000	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	853000	USD
CY2015Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	967000	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	254000	USD
CY2015Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	200000	USD
CY2014Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	32000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	92000	USD
CY2015Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	46000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	123000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	218327000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	237987000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	302156000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	293120000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	500000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44296000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	59437000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	168994000	USD
CY2015Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	173870000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1185000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	292000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8853000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11841000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4313000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6043000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-10845000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46100000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-18927000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46193000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7948000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-35920000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3131000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9317000	USD
CY2015Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	40918000	USD
	us-gaap	Operating Expenses OperatingExpenses	116657000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	51385000	USD
	us-gaap	Operating Expenses OperatingExpenses	139558000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2876000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10042000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-15734000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36725000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	15759000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2290000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2181000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2308000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2327000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	6080000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	573000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5291000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4384000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-457000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-454000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-457000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-454000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2774000	USD
CY2015Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3619000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-677000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1302000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8573000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2468000	USD
CY2015Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5000000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4715000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8853000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7126000	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4022000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4049000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6877000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7043000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	194576000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3090000	USD
CY2014Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2505000	USD
CY2014Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2535000	USD
CY2014Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	2614000	USD
CY2015Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3167000	USD
CY2015Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	3754000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	981000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1925000	USD
CY2014Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1633000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	1829000	USD
CY2014Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	566000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1694000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	992000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2160000	USD
CY2014Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	596000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1139000	USD
CY2015Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1579000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3300000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	216159000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37069000	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	41536000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2669000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2762000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	189521000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2174000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	4283000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7158000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20614000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10035000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	30311000	USD
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1200000	USD
CY2015Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1200000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-578025000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-624218000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	74985000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	87303000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	224106000	USD
CY2014Q3	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	2
	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	2
CY2015Q3	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	2
	us-gaap	Segment Reporting Disclosure Of Major Customers SegmentReportingDisclosureOfMajorCustomers	1
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14870000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43382000	USD
CY2015Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	24194000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	63406000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	18247000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13852000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	912917	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	883047	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	27.31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8386000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	294700	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1838876	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4284000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1847669	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2959320	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.99
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.41
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4275000	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2669160	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.79
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	34.15
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	32.62
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56898281	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	56735944.000	shares
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4060000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M30D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y7M2D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	432525	shares
CY2014Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12600000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	83829000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	55133000	USD
CY2015Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55819242	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	55447414	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Nature of the Business</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Insulet Corporation, the "Company," is primarily engaged in the development, manufacturing and sale of its proprietary OmniPod Insulin Management System (the “OmniPod System”), an innovative, discreet and easy-to-use insulin infusion system for people with insulin-dependent diabetes. The OmniPod System features a unique disposable tubeless OmniPod which is worn on the body for approximately three days at a time and the handheld, wireless Personal Diabetes Manager (“PDM”). Conventional insulin pumps require people with insulin-dependent diabetes to learn to use, manage and wear a number of cumbersome components, including up to </font><font style="font-family:Arial;font-size:10pt;color:#000000;text-decoration:none;">42</font><font style="font-family:Arial;font-size:10pt;"> inches of tubing. In contrast, the OmniPod System features two discreet, easy-to-use devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company acquired Neighborhood Holdings, Inc. and its wholly-owned subsidiaries (collectively, “Neighborhood Diabetes”) in </font><font style="font-family:Arial;font-size:10pt;">June 2011</font><font style="font-family:Arial;font-size:10pt;">, in order to expand the Company’s full-suite diabetes management product offerings and obtain access to a larger number of insulin dependent patients. Through Neighborhood Diabetes, the Company is able to provide customers with blood glucose testing supplies, traditional insulin pumps, pump supplies and pharmaceuticals and has the ability to process claims as either durable medical equipment or through pharmacy benefits.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Commercial sales of the OmniPod System began in the United States in </font><font style="font-family:Arial;font-size:10pt;">2005</font><font style="font-family:Arial;font-size:10pt;">. The Company sells the OmniPod System and other diabetes management supplies in the United States through direct sales to customers or through its distribution partners. The OmniPod System is currently available in multiple countries in Europe and in Canada. </font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July 7, 2015, the Company executed an asset purchase agreement whereby it acquired the Canadian OmniPod distribution operations from GlaxoSmithKline (GSK). With the acquisition, the Company assumed all distribution, sales, marketing, training and support activities for the OmniPod system in Canada. Additional information regarding this acquisition is provided in note 3 to the consolidated financial statements included in this Form 10-Q.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Reclassification of Prior Period Balance</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain reclassifications have been made to prior periods amounts to conform to the current period financial statement presentation. These reclassifications have no effect on previously reported net income.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;text-decoration:none;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expense during the reporting periods. The most significant estimates used in these financial statements include the valuation of; stock-based compensation expense, acquired businesses, accounts receivable, inventories, goodwill, deferred revenue, and equity instruments, the lives of property and equipment and intangible assets, as well as warranty and doubtful accounts allowance reserve calculations. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001145197-15-000066-index-headers.html	Edgar Link	pending
0001145197-15-000066-index.html	Edgar Link	pending
0001145197-15-000066.txt	Edgar Link	pending
0001145197-15-000066-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
podd-20150930.xml	Edgar Link	completed
podd-20150930.xsd	Edgar Link	pending
podd-20150930_cal.xml	Edgar Link	unprocessable
podd-20150930_def.xml	Edgar Link	unprocessable
podd-20150930_lab.xml	Edgar Link	unprocessable
podd-20150930_pre.xml	Edgar Link	unprocessable
podd-2015x09x30_10xq.htm	Edgar Link	pending
podd-ex311_20150930x10q.htm	Edgar Link	pending
podd-ex312_20150930x10q.htm	Edgar Link	pending
podd-ex321_20150930x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2015 Q4 Form 10-Q Financial Statement

#000114519715000066 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2015 Q4 Form 10-Q Financial Statement

#000114519715000066 Filed on November 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd